More‍ than⁤ four years ago, President Donald Trump hailed mRNA vaccines for COVID-19 as “a monumental national achievement” and “one of the greatest miracles in the history of modern-day medicine.” ⁢The mRNA ⁣platform allowed scientists to begin vaccine growth quickly, with clinical trials starting weeks after the virus’s genetic sequence was published and just ‍days after the WHO declared a pandemic.

However, Health and Human Services Secretary Robert F. Kennedy Jr. recently announced the cancellation of over $500⁣ million in HHS ‍contracts supporting mRNA vaccine development. Trump appeared indifferent to this shift, stating, “That was now a long time ago, and we’re⁣ onto other things.”

Researchers and former biosecurity officials fear this move will hinder the⁤ U.S.’s ability to ⁤respond to future health threats, especially as countries like China invest in the technology. Kennedy has criticized mRNA vaccines, claiming they‍ “failed to ⁤protect effectively against upper ‍respiratory infections,”‍ aligning⁤ with his broader anti-vaccine stance and rollback of ‍vaccine policies.

Experts argue Kennedy’s⁤ justifications rely on misrepresented studies and unsupported claims. Jake Scott of Stanford University School of Medicine explained that the goal of mRNA vaccines is to prevent severe disease, not necessarily all infection. Advisers to Kennedy⁢ have made even more unsubstantiated claims, with one suggesting mRNA vaccines were more hazardous than ⁢contracting COVID-19.

Studies ‍estimate COVID vaccines prevented over⁤ 3 million deaths and 18 ⁢million hospitalizations in the U.S. mRNA vaccines are valuable for ⁣pandemic response due to⁤ their rapid development ⁤and adaptability. Traditional “whole ‍virus” vaccines require lengthy and expensive‍ lab cultivation.

HHS will now prioritize⁢ “whole-virus vaccines‍ and novel platforms.” This follows the cancellation of $700 million in funding to ‍moderna ⁣for‍ mRNA influenza vaccine development, including a promising bird flu vaccine. The termination also ended the government’s right to⁣ purchase⁤ pre-pandemic influenza vaccines.

The canceled projects represent crucial late-stage ⁣development that BARDA uniquely funds.Biotech investments in mRNA vaccines may decline, with some investors considering pulling back, and research may shift to other countries.